Skip to content
Resources > Reports

Navigating Biopharma Policy: 2025 Changes and a Look Ahead

By Sara Mallatt, Director of Healthcare Research and Sean Carmichael
IndustryLife Sciences & Healthcare

Biopharma firms are grappling with a turbulent and complex policy landscape. The threat of 100% tariffs on imported branded drugs have fundamentally altered business strategy for firms, spurring dealmaking with the federal government in exchange for tariff relief. Heightened policy uncertainty is forcing manufacturers to reevaluate pricing and go-to-market strategies, with a severe expected revenue impact.

AlphaSense recently hosted a webinar with Dr. Robert Popovian, Chief Science Policy Officer at the Global Health Living Foundation to discuss these issues and more. This report leverages key insights from Dr. Popovian and those available in AlphaSense to explore the key policy shifts shaping the biopharma ecosystem.

About the Authors
  • Sara Mallatt

    Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.
  • Sean Carmichael

    Sean Carmichael

    Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.

Explore more

All articles

Key Debates Transforming Energy and Industrials in 2026

In this report, we harness broker research, Tegus Expert Insights, and company commentary in AlphaSense to explore how eight debates are shaping the energy and industrials landscape in 2026.
ReportEnergyIndustrials
Text: 'Key Debates Transforming Energy and Industrials in 2026' by Xavier Smith and Sean Carmichael. Blue line art illustrations on a grid background show a drone, oil barrels, computer chips, and a mining truck.

The Future of Primary Research: An Evolution of AI-Driven Expert Insights

In this report, we explore the evolution of expert research as AI-driven enhancements streamline inefficiencies and bottlenecks, creating asynchronous workflows. As access proliferates and AI enables faster synthesis, it is increasingly essential for investment teams to harness complete ecosystems to drive high-stakes decisions with conviction.
Report
Text "The Future of Primary Research: An Evolution of AI-Driven Expert Insights" next to a blue AI interface showing a chat between an 'AI Interviewer' and an 'Expert'.

EMEA Outlook 2026: Navigating Inflation, Manufacturing Shifts and AI Adoption

The extent to which EMEA economies can tame inflation, manage weakness in the auto sector, and harness AI for growth will be key to their economic prosperity in the months to come. In this report, we explore how these themes will impact EMEA in the second half of 2026.
Report
Report cover for 'EMEA Outlook 2026: Navigating Inflation, Manufacturing Shifts and AI Adoption' by Shelly Hagan, featuring a globe and an upward trend arrow.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.